Published in Infect Dis Clin North Am on March 01, 2009
Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis (2012) 1.66
Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One (2010) 1.60
Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect (2010) 1.48
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis (2013) 1.32
Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization. J Clin Microbiol (2012) 1.20
Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother (2011) 1.07
Productive steps toward an antimicrobial targeting virulence. Curr Opin Microbiol (2009) 1.02
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum Vaccin Immunother (2012) 0.96
Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors. Clin Infect Dis (2014) 0.93
Initial efforts toward the optimization of arylomycins for antibiotic activity. J Med Chem (2011) 0.90
Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PLoS One (2013) 0.88
Community-Associated Methicillin-Resistant Staphylococcus aureus Lacking PVL, as a Cause of Severe Invasive Infection Treated with Linezolid. Case Rep Pediatr (2013) 0.86
Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area. J Pediatric Infect Dis Soc (2012) 0.84
Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides. J Invest Dermatol (2014) 0.84
Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract (2014) 0.83
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. J Clin Invest (2012) 0.83
Antimicrobial resistance profile of Staphylococcus aureus isolates obtained from skin and soft tissue infections of outpatients from a university hospital in Recife -PE, Brazil. An Bras Dermatol (2012) 0.81
Linkage, mobility, and selfishness in the MazF family of bacterial toxins: a snapshot of bacterial evolution. Genome Biol Evol (2013) 0.79
Molecular epidemiology of community-onset methicillin-resistant Staphylococcus aureus infections in Israel. Eur J Clin Microbiol Infect Dis (2015) 0.78
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine. Infect Immun (2013) 0.77
The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes. PLoS One (2016) 0.77
Methicillin-susceptible Staphylococcus aureus skin infections among military conscripts undergoing basic training in Bangkok, Thailand, in 2014. BMC Res Notes (2016) 0.75
Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries. PLoS One (2015) 0.75
Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review. J Trop Med (2016) 0.75
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 4.71
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol (2007) 3.25
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis (2005) 3.21
Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 3.16
Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics (2005) 3.13
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J (2004) 2.91
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J (2002) 2.47
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2005) 2.28
Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics (2006) 2.17
Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother (2002) 2.12
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2006) 2.10
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J (2003) 1.76
Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J (2007) 1.65
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J (2007) 1.65
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother (2005) 1.57
Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J (2006) 1.57
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol (2009) 1.55
Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine (2010) 1.44
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics (2006) 1.41
Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect (2012) 1.40
Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J (2004) 1.39
Hepatosplenic cat-scratch fever. Lancet Infect Dis (2008) 1.38
The changing face of pleural empyemas in children: epidemiology and management. Pediatrics (2004) 1.29
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J (2005) 1.27
Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J (2002) 1.22
Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics (2008) 1.20
Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis (2003) 1.19
Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J (2003) 1.14
Streptococcus pneumoniae infections in the neonate. Pediatrics (2003) 1.14
Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J (2009) 1.14
Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics (2006) 1.13
Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J (2013) 1.13
Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol (2008) 1.12
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J (2002) 1.09
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis (2007) 1.08
Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother (2011) 1.06
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol (2010) 1.02
Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol (2008) 1.01
Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J (2011) 0.96
Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J (2010) 0.96
Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila) (2002) 0.95
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol (2011) 0.95
Hematologic effects of linezolid in young children. Pediatr Infect Dis J (2003) 0.94
Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant (2007) 0.93
Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine (2005) 0.93
Cat-scratch disease occurring in three siblings simultaneously. Pediatr Infect Dis J (2003) 0.91
Toxocariasis causing eosinophilic ascites. Pediatr Infect Dis J (2008) 0.90
Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am (2012) 0.89
Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics (2007) 0.88
Pneumococcal endocarditis in children. Clin Infect Dis (2004) 0.86
Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol (2012) 0.86
Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States. J Clin Microbiol (2004) 0.86
Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol (2013) 0.86
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother (2003) 0.85
Needle aspiration for the etiologic diagnosis of children with cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus. Clin Pediatr (Phila) (2011) 0.85
Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old. Pediatr Infect Dis J (2014) 0.84
Nasal Staphylococcus aureus colonization among mothers of term and late preterm previously healthy neonates with community-acquired Staphylococcus aureus infections. Pediatr Infect Dis J (2011) 0.84
Ampicillin and penicillin concentration in serum and pleural fluid of hospitalized children with community-acquired pneumonia. Pediatr Infect Dis J (2004) 0.84
Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother (2014) 0.82
USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J (2009) 0.82
Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J (2016) 0.82
Recurrent community-associated Staphylococcus aureus infections in children presenting to Texas Children's Hospital in Houston, Texas. Pediatr Infect Dis J (2013) 0.81
Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J (2009) 0.81
Community-acquired staphylococcal musculoskeletal infection in infants and young children: necessity of contrast-enhanced MRI for the diagnosis of growth cartilage involvement. AJR Am J Roentgenol (2012) 0.81
Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J (2014) 0.80
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J (2016) 0.79
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J (2003) 0.79
Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media. Otolaryngol Head Neck Surg (2004) 0.79
Staphylococcus aureus infections in HIV-positive children and adolescents. Pediatr Infect Dis J (2012) 0.79
Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. J Biol Chem (2012) 0.78
The Contemporary Microbiology and Rates of Concomitant Osteomyelitis in Acute Septic Arthritis. Pediatr Infect Dis J (2016) 0.78
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother (2010) 0.76
Altered neutrophil counts at diagnosis of invasive meningococcal infection in children. Pediatr Infect Dis J (2013) 0.76
Meningococcal control in the United States and Africa. J Infect Dis (2006) 0.76
Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol (2010) 0.76
Staphylococcus aureus bacteremia without a localizing source in pediatric patients. Pediatr Infect Dis J (2014) 0.76
Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop (2010) 0.75
Corticosteroids for acute bacterial meningitis. Ann Emerg Med (2009) 0.75
Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J (2003) 0.75
Abdominal pain and fever in an adolescent. Semin Pediatr Infect Dis (2005) 0.75
An Hepatic Abscess in a Patient With Sickle Cell Anemia. Pediatr Infect Dis J (2016) 0.75
Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J (2017) 0.75
Severe staphylococcal infections in children. Pediatr Ann (2008) 0.75
Pediatric Prostatic Abscess Caused by Methicillin-susceptible Staphylococcus aureus. Pediatr Infect Dis J (2016) 0.75
St. Louis encephalitis in early infancy. Pediatr Infect Dis J (2004) 0.75
Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J (2017) 0.75
The Influence of the Route of Antibiotic Administration, Methicillin-Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. Pediatr Infect Dis J (2016) 0.75
Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children. Pediatr Infect Dis J (2015) 0.75
A bullous lesion in a neutropenic adolescent. Pediatr Emerg Care (2009) 0.75
A conversation with Sheldon L. Kaplan, MD. Interview by Stanford T Shulman. Pediatr Ann (2013) 0.75
Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J (2015) 0.75
Fever and rash complicating osteomyelitis. Semin Pediatr Infect Dis (2004) 0.75
An eighteenth-century disease in the year 2001. Semin Pediatr Infect Dis (2002) 0.75
Painful labia ulceration and neuroretinal cat scratch disease. Pediatr Infect Dis J (2013) 0.75